VANGUARD GROUP INC - KITE PHARMA INC ownership

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of KITE PHARMA INC
ValueSharesWeighting
Q3 2017$736,143,000
+77.6%
4,094,002
+2.4%
0.03%
+70.0%
Q2 2017$414,501,000
+44.2%
3,998,269
+9.2%
0.02%
+33.3%
Q1 2017$287,395,000
+103.2%
3,661,547
+16.1%
0.02%
+87.5%
Q4 2016$141,437,000
-16.5%
3,154,258
+4.0%
0.01%
-20.0%
Q3 2016$169,487,000
+15.5%
3,034,136
+3.4%
0.01%
+11.1%
Q2 2016$146,771,000
+15.8%
2,935,406
+6.3%
0.01%
+12.5%
Q1 2016$126,782,000
-21.7%
2,761,527
+5.0%
0.01%
-27.3%
Q4 2015$162,020,000
-31.5%
2,629,342
-38.1%
0.01%
+22.2%
Q3 2015$236,444,000
+137.8%
4,246,476
+160.4%
0.01%
+28.6%
Q2 2015$99,415,000
+13.4%
1,630,554
+7.3%
0.01%
+16.7%
Q1 2015$87,689,000
+109.3%
1,520,269
+109.3%
0.01%
+100.0%
Q4 2014$41,890,000
+192.3%
726,363
+44.5%
0.00%
+200.0%
Q3 2014$14,330,000502,8200.00%
Other shareholders
KITE PHARMA INC shareholders Q4 2017
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,358,084$135,991,00055.96%
Lamond Capital Partners LLC 365,900$21,101,00013.82%
EcoR1 Capital, LLC 438,400$25,283,00012.80%
DSAM Partners (London) Ltd 399,571$23,043,0006.08%
Silver Rock Financial LLC 476,563$27,483,0005.08%
Cormorant Asset Management, LP 255,000$14,706,0002.27%
Opaleye Management Inc. 76,000$4,383,0002.22%
Ghost Tree Capital, LLC 60,000$3,460,0001.66%
SPHERA FUNDS MANAGEMENT LTD. 110,970$6,400,0001.09%
PURA VIDA INVESTMENTS, LLC 44,250$2,552,0000.94%
View complete list of KITE PHARMA INC shareholders